Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method
about
Preparation and characterization of magnetic alginate-chitosan hydrogel beads loaded matrine.Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencingDevelopment and validation of an UPLC-MS/MS method for the quantification of ethoxzolamide in blood, brain tissue, and bioequivalent buffers: applications to absorption, brain distribution, and pharmacokinetic studies.Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein.Development and validation of an UPLC-MS/MS method for the quantification of columbin in biological matrices: Applications to absorption, metabolism, and pharmacokinetic studies.Simultaneous Determination of Matrine and Tinidazole in Compound Lotion by RH-HPLC MethodDeveloping an activity and absorption-based quality control platform for Chinese traditional medicine: Application to Zeng-Sheng-Ping(Antitumor B).Validated LC-MS/MS method for the determination of 3-hydroxflavone and its glucuronide in blood and bioequivalent buffers: application to pharmacokinetic, absorption, and metabolism studies.Factors Influencing Oral Bioavailability of Thai Mango Seed Kernel Extract and Its Key Phenolic Principles.Validated LC-MS/MS method for the determination of maackiain and its sulfate and glucuronide in blood: application to pharmacokinetic and disposition studies.Matrine Directly Activates Extracellular Heat Shock Protein 90, Resulting in Axonal Growth and Functional Recovery in Spinal Cord Injured-Mice.Some pharmacokinetic parameters of salvianolic acid A following single-dose oral administration to ratsA Comprehensive Review on Pharmacokinetic Profile of Some Traditional Chinese Medicines
P2860
Q34076504-951BCC22-0A93-41B4-B1AC-D0DDCE64B9DBQ35214938-8BEF1742-78A9-4AC3-BABF-5E0B79B4E9D1Q35866582-ADFCD041-8859-4465-93FB-E8235D78C2A6Q36105337-F8B107C3-E0DE-4EE6-A4EB-EB192EB98C7BQ36296183-BCDC48B4-C965-4813-91E8-F0E3E1F9B60CQ36319303-0DD3991E-D8BD-4A25-9A7B-0CB125B2FD7AQ37067649-C7EA6DDD-B16B-422E-9D03-F24E52789A0CQ38861132-B86E4CB6-684F-48AB-9A71-66DA164DC091Q39230354-AC355EB7-2067-44C6-8C0F-A5748AC9C86DQ40245861-3D02DCD5-380C-42B5-B412-85C447453463Q42149324-26DBC9B1-5E48-4A95-BE20-B49033C1FC97Q55266209-899B1F7D-AF5A-4271-A88A-C97420CC8D78Q57126993-90C7D48F-94BA-4645-827B-4909678D1C64Q59141398-ACFFCD79-AE0B-416E-910F-A438C9A79F0A
P2860
Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@ast
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@en
type
label
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@ast
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@en
prefLabel
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@ast
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@en
P2093
P2860
P1476
Biopharmaceutical and pharmaco ...... e and robust UPLC-MS/MS method
@en
P2093
Kaustubh H Kulkarni
Taijun Yin
P2860
P304
P356
10.1016/J.JPBA.2009.11.020
P577
2009-11-26T00:00:00Z